Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgain AMS on Instagram

AMS eLearning Website access

AMS has made the AMS eLearning site easier to access for all members.

All members who were not registered on the site have now been added at https://elearning.menopause.org.au/ and pre-enrolled in all available courses.

Members who were already registered on the site have now been pre-enrolled in all courses as well.

This simply means that should you wish to undertake any of the courses you can do so immediately.

2020-22 Points apply to the courses.

elearn AMS

Gaining Access

An email will be sent to you with access instructions and a password. Your username is your email address.

You may access your eLearnAMS account through forgotten password with your email address immediately.

elearn AMS access

Please contact This email address is being protected from spambots. You need JavaScript enabled to view it. for assistance if needed. 

Content created August 2020

Print Email

Menopause Hormone Therapy Dos and Don'ts

Prof R. Baber - Australia 

An update on MHT prescribing principles and options:

  1. Global Consensus Statement on use of MHT

  2. Benefits of MHT

  3. Adverse effects of MHT

  4. How to prescribe MHT

Prof T Hillard - UK

The do’s and dont’s of prescribing:

  1. Consider the estrogen and progestogen parts of HT as 2 separate and variable components

  2. Consider changing the type of progestogen if experiencing side-effects

  3. Consider changing dose and/or route of estrogen if symptom control not achieved

  4. Don’t start no bleed combinations too early or there maybe irregular bleeding

  5. Don’t forget vaginal estrogens can be used in conjunction with systemic treatment if there are persistent VVA symptoms.

Print Email

Menopause Essentials Update 2019

Menopause Essentials UpdateThe AMS Board is pleased to continue this very popular Menopause Essentials Update series.

Upcoming Presentations

Saturday 25 May 2019

1.30-5.30pm

The Victoria Hotel, 215 Little Collins St, Melbourne

This update on Menopause is aimed at GP’s, gynaecologists, endocrinologists and other health professionals who are seeking a comprehensive review of the current issues that face them in the diagnosis and management of menopausal symptoms. Presentations will include case studies and there will be time for questions.

Topics include:

  • Decision making at menopause
  • Menopausal hormone therapy (MHT): What’s new?
  • Managing menopause without hormones
  • MHT in difficult circumstances

Download flyer here:  pdfMenopause Essentials Update May 2019851.96 KB

Speakers

speakers

Register

Go to Trybooking at: https://www.trybooking.com/BAEOV

 

Continuing Education

QI&CPD

Royal Australian and New Zealand College of Obstetricians and Gynaecologists  (RANZCOG) Approved O&G Workshop (Clinical Expertise Domain) 3 PD points.

 Support

Besins

The AMS thanks Besins Healthcare for the unrestricted education grant that has made this Menopause Essentials Update possible.

Content updated February 2019

 

Print Email

Menopause Essentials Update 2020

MEU Perth 2020The AMS Board is pleased to continue this very popular Menopause Essentials Update series.

Upcoming Presentations

Perth, Saturday 14 November 2020

1.30-5.00pm

Seminar Room 4, University Club of Western Australia
University of Western Australia, 35 Stirling Hwy, Crawley, WA 6009

This update on Menopause is aimed at GP's, gynaecologists, endocrinologists and other health professionals who are seeking a comprehensive review of the current issues that face them in the diagnosis and management of menopausal symptoms.

Presentations will include case studies and there will be time for questions. 

Topics include:

  • Decision making at menopause
  • Menopausal hormone therapy (MHT): What’s new?
  • Managing menopause without hormones
  • MHT in difficult circumstances

Download flyer here: pdfMenopause Essentials Update 2020466.12 KB

Presenters

Dr Ashley Makepeace MBBS FRACP

Dr Ashley MakepeaceDr Ashley Makepeace is a clinical Endocrinologist and completed her Endocrinology training in Western Australia and in Oxford, UK. Her public appointment is at Fiona Stanley and Fremantle Hospitals. She consults in private with interests in type 1 diabetes, bone health and women’s health and works as an Endocrinologist within a fertility clinic. She is a guest lecturer for the medical curriculum at Notre Dame University, Fremantle. She is the chair of a local interest group of Endocrinologists and Clinical Biochemists with a focus on women’s health.

Dr Nely Shrestha Khatri MBBS FRACP

Dr Nely Shrestha KhatriDr Nely Shrestha Khatri is a Consultant Endocrinologist at Fiona Stanley Hospital. She undertook advanced training at Sir Charles Gairdner Hospital and Fiona Stanley Hospital. She underwent further training in obstetric medicine and endocrine disorders in pregnancy at King Edward Memorial Hospital. She was awarded Fellowship of the Royal Australasian College of Physicians in Endocrinology in 2018 and Obstetric Medicine Certificate by SOMANZ in 2019. She has private practices at Keogh Institute for Medical Research, Nedlands and Rockingham Specialist Centre.

Dr Lucy Williams MBBS FRANZCOG

Dr Lucy WilliamsDr Lucy Williams is a Consultant Gynaecologist with a Masters in reproductive endocrinology and infertility. She works as a sessional gynaecologist at King Edward Memorial Hospital for Women in the Menopause and Fertility Clinics. She is also Medical Director of Concept Fertility Centre and consults in general Gynaecology and Fertility at Hollywood Medical Centre.

 

Dr Jennifer Ng MBBS (HONS) FRACP

Dr Jennifer NgDr Jennifer Ng is an Endocrinologist at the Keogh Institute for Medical Research and Hollywood Medical Centre in Nedlands. She completed her MBBS in 2000 at the University of Western Australia, Physician Training at Royal North Shore Hospital in Sydney, and Endocrinology training at Royal Perth and Sir Charles Gairdner Hospitals in Perth. In 2008 she undertook a clinical and research fellowship in Obstetric Medicine at the B.C. Women’s Hospital in Vancouver, Canada. She has additional experience in Clinical Biochemistry.

Cost

AMS members: FREE
Non-members: $50

Register

Go to Trybooking at: https://www.trybooking.com/BLLHX

Continuing Education

RACGP CPD points 2020 ACRRM Accredited Activity

Content updated Sptember 2020

Print Email

Education

AMS Congress

The Australasian Menopause Society holds a scientific meeting (Congress) each year.

The AMS Congress involves plenary lectures, interactive sessions and panel discussions.

These meetings are planned three years in advance, building on the topics and experiences of past successful annual scientific meetings as well as drawing on the outcomes of recent research.

Next congress

HP eNews

The AMS publishes a regular email newsletter, HP eNews, for doctors and other healthcare professionals who have a special interest in women's health. The content covers information and resources relevant to menopause, midlife and the promotion of healthy ageing.

Subscribe at right

Simply add your name and email address.

Menopause Essentials Update

Menopause Essentials Update

Menopause Updates are a new initiative of the Australasian Menopause Society in response to requests from many GPs for up to date evidence based information and guidance in managing women’s midlife health issues including menopause. 

For AMS Members

Case Studies

AMS Members have access to Case Studies relevant to women's health management.

Educational Slides

The International Menopause Society has provided access to their Educational Slide Kit for AMS Members.

eLearning Website

See the site here: https://elearning.menopause.org.au/

Members have been pre-registered and have access (pre-enrolled) for all courses.

ams elearning 2018

For access to these and more materials become a member.

 

Content updated August 2020

Print Email

19th AMS Congress Prize Winners

Winner of the Barbara Gross Award 

Dr Carolyn EeDr Carolyn Ee

Acupuncture for menopausal hot flushes: an individually randomised sham-controlled trial

Dr Carolyn Ee, Department of General Practice, University of Melbourne
Prof Charlie Xue, School of Health Sciences, RMIT University
Dr Patty Chondros, Department of General Practice, University of Melbourne
Prof Stephen P Myers, NatMed-Research Unit, Southern Cross University
Assoc Prof Simon D French, School of Rehabilitation Therapy, Queen’s University
Prof Helena Teede, Diabetes Unit, Monash Health
Assoc Prof Marie Pirotta, Department of General Practice, University of Melbourne 

Background
Menopausal hot flushes affect up to 75% of women and pose a significant health and financial burden. Acupuncture is a safe treatment with conflicting evidence for efficacy as a hot flush treatment.

Aims

To assess the efficacy of acupuncture against sham acupuncture for
menopausal hot flushes.

Methods

We included Australian women aged over 40 in the late menopausal transition or postmenopause with at least seven moderate hot flushes daily, meeting criteria for the Chinese Medicine diagnosis of Kidney Yin deficiency. Exclusion criteria included breast cancer and hormone replacement therapy. Women were randomised, stratified by acupuncturist, to ten treatments over eight weeks of standardised Chinese medicine needle acupuncture designed to treat Kidney Yin deficiency, or non-insertive sham acupuncture. Participants, outcome assessors and investigators were blinded to treatment allocation. Primary outcome was the seven day Hot Flush Diary score at end-of-treatment (EOT). Secondary outcomes included quality-oflife, anxiety, depression, credibility, and expectancy. Participants were assessed at four weeks, end-of-treatment, then three and six months post-treatment. Analysis was by intention to treat using mixed effects modelling.

Results

327 women were randomised to real (n=163) or sham acupuncture (n=164). At EOT, 16% and 13% were lost to follow up. There was no evidence of a between-group difference in hot flush scores at end-oftreatment (mean difference 0·33; 95% CI -1·87 to 2·52; p=0·77) or for secondary outcomes, and no serious adverse events.

Conclusion

Chinese medicine acupuncture did not exert additional benefit over sham treatment for women with moderately-severe menopausal hot flushes.

Winner of the AMS Scientific Award 

Dr Pragya GartoullaDr Pragya Gartoulla 

For her paper: “Moderate-severe vasomotor symptoms are associated with lowered psychological general well-being in women at midlife”

Pragya Gartoulla, Robin J. Bell, Roisin Worsley and Susan R. Davis.
Women’s Health Research Program Department of Epidemiology and Preventive Medicine Monash University.

Abstract

Aim: To investigate the association between moderate-severe vasomotor symptoms (VMS) and psychological general well-being in women at midlife, taking into account sociodemographic and lifestyle factors.

Methods: We recruited 2020 Australian women, aged 40-65 years, to a cross-sectional survey between October 2013 and March 2014. Well-being was assessed by the Psychological and General Well-being Questionnaire (PGWB), with a higher score indicating greater well-being, and VMS by the Menopause-specific Quality of Life Questionnaire. Linear regression analysis was performed to assess the direction and strength of associations.

Results: 72.83% (95% CI 70.60 to 75.07) of women were peri/postmenopausal and 11.38% (95% CI 9.67 to 13.09) reported moderatesevere VMS. Moderate-severe VMS had a strong negative association with the total PGWB score ( = -8.17, 95% CI -10.90 to -5.45). The sociodemographic factors associated with a lower PGWB score included being un-partnered ( = -2.80, 95% CI -4.74 to -0.86), obese ( = -5.46, 95% CI -7.24 to -3.68) and a smoker ( = -3.47, 95% CI -6.10 to -0.84). Older age ( = 0.29, 95% CI 0.06 to 0.42) and participation in paid and/or volunteer work ( = 2.72, 95% CI 0.61 to 4.82) were positively associated with the total PGWB score. For those with insecure housing, being a carer was associated with better well-being.

Conclusions: Moderate-severe VMS are significantly and independently negatively associated with psychological general well-being in women at midlife. This consequence of VMS needs to be considered in the decision making about the treatment of moderate-severe VMS.

Winner of the Jean Hailes Memorial Prize 

Dr Lydia BrownDr Lydia Brown 

Self Compassion: A Resilience Factor during the Menopause Transition

Authors: Lydia Brown (a); Christina Bryant (a, c); Valerie Brown (a); Bei Bei (b, d); Fiona Judd(c, d)
a. Melbourne School of Psychological Sciences, University of Melbourne
b. Centre for Women’s Mental Health, Royal Women’s Hospital
c. Department of Psychiatry, University of Melbourne
d. School of Psychological Sciences, Monash University

Abstract:

There is a wide variation in women’s experience of menopause, whereby some women find that menopause impacts their well-being more than others. This two-part study aimed to investigate the roles of selfcompassion (studies 1 and 2) and beliefs about the menopause (study 2) in predicting daily life functioning, depressive symptoms and well-being in a community sample of 206 midlife women currently reporting menopausal hot flushes and night sweats (HFNS). In a path analytic model, Study 1found that self-compassion predicted low hot flush daily interference ratings ( = -.37), and also moderated the relationship between HFNS frequency and daily interference ( = -.21), such that women high on self-compassion were less impaired by hot flushes, and subsequently symptoms of depression. Study 2 extended these findings to demonstrate that selfcompassion, women’s beliefs about control over menopause and HFNS interference ratings predicted high hedonic and eudaimonic wellbeing, whereas biological aspects of menopause including menopausal stage and HFNS frequency did not. Taken together, these studies demonstrate psychological aspects of the menopause including menopause beliefs and self-compassion help explain individual differences in well-being in the context of menopause. Clinical care that fosters a woman’s sense of control over symptoms, together with advice on self-compassion could be a useful strategy to promote functioning and well-being across the menopause transition.

Print Email

CPD Points AMS Congress 2014

All CPD points have now been approved for each of the AMS Pre-Congress workshops and also the AMS Congress as listed below. 

AMS Update on the Menopause – Menopause Essentials

RACGP Activity 7701 – This activity has been approved by the RACGP QI&CPD Program in the 2014-2016 triennium.  Total 6 x Category 2 points.

ACRRM Activity E1401AMSO – 3 Core points, 2014-2016 triennium

RANZCOG 

  • Paper-based CPD Program participants can claim 4 CPD points (for full attendance) under the Meeting Attendance category
  • CPD Online Program participants can claim 4 PD points (for full attendance) in the Clinical Expertise Domain

RNZCGP has endorsed and approved this activity for up to 3.0 credits CME for General Practice Educational Program Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes. 

AMS Update on the Menopause – Breast Cancer and Menopause

RACGP Activity 8746 – This activity has been approved by the RACGP QI&CPD Program in the 2014-2016 triennium.  Total 6 x Category 2 points. 

ACRRM Activity E1402AMSO - 3 Core points, 2014-2016 triennium 

RANZCOG 

  • Paper-based CPD Program participants can claim 4 CPD points (for full attendance) under the Meeting Attendance category
  • CPD Online Program participants can claim 4 PD points (for full attendance) in the Clinical Expertise Domain

RNZCGP has endorsed and approved this activity for up to 3.0 credits CME for General Practice Educational Program Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes

AMS Update on the Menopause – Menopause Essentials & Breast Cancer and Menopause

RACGP Activity 8755 – This activity been approved by the RACGP QI&CPD Program in the 2014-2016 triennium. Total 40 x Category 1 points, in Women’s Health. 

ACRRM Activity E1403AMSO – 14 PRPD points + 14 PRPD O&G MOPS points, 2014-2016 triennium.

RANZCOG 

  • Paper-based CPD Program participants can claim 7 CPD points (for full attendance) under the Meeting Attendance category
  • CPD Online Program participants can claim 7 PD points (for full attendance) in the Clinical Expertise Domain 

RNZCGP has endorsed and approved this activity for up to 6.0 credits CME for General Practice Educational Program Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes

Full ALM attendance is eligible for one day Obstetrics Procedural Grant for eligible GPs.  GPs must be registered in the Rural Procedural Grants Program prior to attending the workshop.  For further information on grant procedure please contact Pauline Curtis, RACGP Email:This email address is being protected from spambots. You need JavaScript enabled to view it.or Maria Trueman, ACRRM Email:This email address is being protected from spambots. You need JavaScript enabled to view it.

18thCongress of the Australasian Menopause Society – The Heart of the Matter – Saturday 27th& Sunday 28thSeptember, 2014 (2 days)

RACGP Activity 8027 (2 days) – This activity has been approved by the RACGP QI&CPD Program in the 2014-2016 triennium.  Total 19 x Category 2 points.

RACGP Activity 11154 (Saturday only) – This activity has been approved by the RACGP QI&CPD Program in the 2014-2016 triennium.  Total 10 x Category 2 points.

RACGP Activity 11155 (Sunday only) – This activity has been approved by the RACGP QI&CPD Program in the 2014-2016 triennium.  Total 9 x Category 2 points. 

ACRRM Activity E1404AMSO – 10 Core points, 2014-2016 triennium (Full Attendance).  Full day Saturday or full day Sunday only points will be available when sign in sheet submitted post Congress. 

RANZCOG 

  • Paper-based CPD Program participants (Meeting Attendance category)
    - Full attendance - 11 Meeting points
    - Attendance 27thSeptember, 2014 - 6 Meeting points
    - Attendance 28thSeptember, 2014 – 6 Meeting points 
  • CPD Online Program participants (Clinical Expertise Domain)
    - Full attendance - 11 PD points
    - Attendance 27thSeptember, 2014 - 6 PD points
    - Attendance 28thSeptember, 2014 – 6 PD points 

RNZCGP has endorsed and approved this activity for up to: 

Full Attendance - 9.5 credits CME for General Practice Educational Program Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes

Saturday only – 5 credits CME for General Practice Educational Program Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes

Sunday only – 4.5 credits CME for General Practice Educational Program Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes

Full 2 Day Congress attendance is eligible for one day Obstetrics Procedural Grant for eligible GPs.  GPs must be registered in the Rural Procedural Grants Program prior to attending the workshop. 

 

Print Email

Clinical Trial Update 2012

From the AMS Congress 2012:

One of the most popular AMS Congress sessions is the annual Clinical Trial Update, presented by Dr Sonia Davison, MBBS FRACP PhD from the Women's Health Research Program at the School of Public Health and Preventive Medicine at Monash University.

Because of the interest in this session, Dr Davison's slide presentation is now available for downloading.

pdfAMS Clinical Trials Update 2012 S Davison Oct 2012228.1 KB

Note: Speaker presentation slides

Slide presentations from the speakers at the AMS 16th National Congress 12-14 October 2012 in Melbourne are available for members

 

Content updated  31 October 2012

Print Email

AMS Active Learning Module 2013

The Assessing and Managing Menopause Active Learning Module (ALM) has been developed for General Practitioners who are interested in learning more about the management of menopause in primary practice.

AMS Education Website

The activity is an RACGP accredited Category 1 activity (total points: 40 Category 1).

Learning Objectives

At the end of the activity, the participant should:

  • Be able to confidently assess and appropriately manage menopausal women
  • Have practised skills in diagnosing and managing menopause
  • Understand the limitations of treatment options for menopausal women
  • Know when specialist referral of menopausal patients is appropriate

Website: http://education.menopause.org.au/

ALM Registration

To undertake the ALM, it is necessary for all participants to:

1. Enrol for the ALM package

ALM enrolments are being managed by the AMS Secretariat. Participation in the ALM will be free of charge to all AMS Members i.e. paid to December 2013. For non-members, a $50 fee will apply.

Go to AMS ALM 2013 Registration to enrol online 
http://www.menopause.org.au/health-professionals/ams-congress-2013/alm-registration-request

Enrolled participants will be provided with a password to access the online module and complete each of the parts of the ALM. 

2. Also register and pay to attend the Australasian Menopause Society Pre-congress Update

This will be in Adelaide from 9am to 12.30pm on Friday 6 September, 2013

For registration details go to: www.sapmea.asn.au/conventions/ams2013/rego.html 

ALM Content Outline 2013

Part 1 – Predisposing Activity (30 mins)
                This must be completed before proceeding to Part 2

Part 2 – Attend Pre-Congress Update 6 September, in Adelaide (3 hours)

Part 3 – Complete Case Studies Activity (1.5 Hours)

Part 4 – Complete Research Update Activity (1.5 Hours)

Part 5 – Complete Reinforcing Activity Evaluation (30 mins)

Part 6 – Evaluation 

Content updated 21 July 2013

Print Email

More Articles ...

Search

Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgainAMS on Instagram